Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Biogen Idec, Inc.
(NQ:
BIIB
)
235.95
USD
+4.62 (+2.00%)
Streaming Delayed Price
/ Updated:
11:19 AM EDT, May 22, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
593,499
Open
232.27
Bid (Size)
235.79 (200)
Ask (Size)
236.03 (300)
Prev. Close
231.33
Today's Range
230.06 - 238.83
52wk Range
126.39 - 231.99
Shares Outstanding
237,374,815
Dividend Yield
N/A
Top News
More News
Recent 52-Week High Exceeded in Shares of Biogen Idec (BIIB)
Today 10:43 EDT
from
Comtex SmarTrend® News Briefs
Free Research Reports on BIIB, CCL, KMX and SKS Issued by the Paragon Report
Today 8:20 EDT
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT
Read More
from
Marketwired News Releases
More News
Read More
49.9% Return Seen to Date on SmarTrend Biogen Idec Call (BIIB)
May 21, 2013
from
Comtex SmarTrend® News Briefs
Biogen Idec Submits BLA to FDA for Approval of PLEGRIDY for Multiple Sclerosis
May 21, 2013
category
Contracts
,
Management
,
Benzinga
, and 5 more.
from
Latest Articles from Benzinga.com
RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market
May 21, 2013
from
Business Wire News Releases
Biogen Idec presenta solicitud ante la FDA para aprobación de PLEGRIDY™ (Peginterferón Beta-1a) sobre esclerosis múltiple
May 21, 2013
from
Business Wire Spanish
Biogen Idec Submits Application to FDA for Approval of PLEGRIDY™ (Peginterferon Beta-1a) in Multiple Sclerosis
May 21, 2013
from
Business Wire News Releases
Biogen's (BIIB) BG-12 Data Not Inflated
May 20, 2013
from
StreetInsider.com News Articles
Leerink Swann Highlights Big Gains in Prescriptions for Biogen's MS Treatment
May 20, 2013
category
Benzinga
,
News
,
BIIB
, and 2 more.
from
Latest Articles from Benzinga.com
Biogen (BIIB) Weeks-6 TECFIDERA Scripts Continue to Ramp
May 20, 2013
from
StreetInsider.com News Articles
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here